7KGY | pdb_00007kgy

Beta-glucuronidase from Faecalibacterium prausnitzii bound to the inhibitor UNC10201652-glucuronide


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free: 
    0.193 (Depositor) 
  • R-Value Work: 
    0.147 (Depositor) 
  • R-Value Observed: 
    0.147 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7KGY

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract.

Zhang, J.Walker, M.E.Sanidad, K.Z.Zhang, H.Liang, Y.Zhao, E.Chacon-Vargas, K.Yeliseyev, V.Parsonnet, J.Haggerty, T.D.Wang, G.Simpson, J.B.Jariwala, P.B.Beaty, V.V.Yang, J.Yang, H.Panigrahy, A.Minter, L.M.Kim, D.Gibbons, J.G.Liu, L.Li, Z.Xiao, H.Borlandelli, V.Overkleeft, H.S.Cloer, E.W.Major, M.B.Goldfarb, D.Cai, Z.Redinbo, M.R.Zhang, G.

(2022) Nat Commun 13: 136-136

  • DOI: https://doi.org/10.1038/s41467-021-27762-y
  • Primary Citation Related Structures: 
    7KGY, 7KGZ

  • PubMed Abstract: 

    Emerging research supports that triclosan (TCS), an antimicrobial agent found in thousands of consumer products, exacerbates colitis and colitis-associated colorectal tumorigenesis in animal models. While the intestinal toxicities of TCS require the presence of gut microbiota, the molecular mechanisms involved have not been defined. Here we show that intestinal commensal microbes mediate metabolic activation of TCS in the colon and drive its gut toxicology. Using a range of in vitro, ex vivo, and in vivo approaches, we identify specific microbial β-glucuronidase (GUS) enzymes involved and pinpoint molecular motifs required to metabolically activate TCS in the gut. Finally, we show that targeted inhibition of bacterial GUS enzymes abolishes the colitis-promoting effects of TCS, supporting an essential role of specific microbial proteins in TCS toxicity. Together, our results define a mechanism by which intestinal microbes contribute to the metabolic activation and gut toxicity of TCS, and highlight the importance of considering the contributions of the gut microbiota in evaluating the toxic potential of environmental chemicals.


  • Organizational Affiliation
    • Department of Food Science, University of Massachusetts, Amherst, MA, USA.

Macromolecule Content 

  • Total Structure Weight: 279.05 kDa 
  • Atom Count: 20,821 
  • Modeled Residue Count: 2,367 
  • Deposited Residue Count: 2,432 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Beta-glucuronidase
A, B, C, D
608Faecalibacterium prausnitziiMutation(s): 0 
Gene Names: uidAERS852426_02720
EC: 3.2.1.31

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
I9G
(Subject of Investigation/LOI)

Query on I9G



Download:Ideal Coordinates CCD File
E [auth A],
G [auth B],
I [auth C],
J [auth D]
8-(4-beta-D-glucopyranuronosylpiperazin-1-yl)-5-(morpholin-4-yl)-1,2,3,4-tetrahydro[1,2,3]triazino[4',5':4,5]thieno[2,3 -c]isoquinoline
C26 H33 N7 O7 S
AQRGEQSNANJABA-WFFUTXBBSA-N
GOL

Query on GOL



Download:Ideal Coordinates CCD File
F [auth A],
H [auth B],
K [auth D]
GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.20 Å
  • R-Value Free:  0.193 (Depositor) 
  • R-Value Work:  0.147 (Depositor) 
  • R-Value Observed: 0.147 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 114.52α = 90
b = 128.405β = 90
c = 177.264γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM137286

Revision History  (Full details and data files)

  • Version 1.0: 2021-11-10
    Type: Initial release
  • Version 1.1: 2022-01-26
    Changes: Database references
  • Version 1.2: 2023-10-18
    Changes: Data collection, Refinement description